Scientists have used cutting-edge imaging techniques to shed light on the progression of Parkinson’s disease by studying how the main culprit, the protein alpha-synuclein, disrupts cellular metabolism.
Scientists have used cutting-edge imaging techniques to shed light on the progression of Parkinson’s disease by studying how the main culprit, the protein alpha-synuclein, disrupts cellular metabolism.